Please login to the form below

Not currently logged in
Email:
Password:

The Medicines Company strengthens board of directors

Paris Panayiotopoulos joins from ARIAD Pharmaceuticals

The Medicines Company has appointed Paris Panayiotopoulos to serve as a director and he's set to stand for election at the company’s 2017 annual meeting of stockholders.

Panayiotopoulos has held a number of previous leadership roles - most recently as president and chief executive officer and a member of the board of directors for ARIAD.

He said: “ I am delighted to be joining The Medicines Company, especially at such an important time.

“I look forward to working with the board in helping to support management in driving the company’s continued growth and success.”

Prior to joining ARIAD, Panayiotopoulos served as president of EMD Serono - the North American biopharmaceutical business of Merck KGaA - after serving as president of Merck Serono, Tokyo.

Clive Meanwell, chief executive officer and director of The Medicines Company, said: “We are pleased to welcome someone of Paris’s caliber to The Medicines Company board of directors.

“His strong leadership background will make him a valuable addition as we continue to execute on our strategic initiatives for the benefit of all shareholders.”

3rd April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics